%D0%96%D0%B0%D0%B2%D0%BE%D1%80%D0%BE%D0%BD%D0%BA%D0%BE%D0%B2,_%D0%90%D0%BB%D0%B5%D0%BA%D1%81%D0%B0%D0%BD%D0%B4%D1%80_%D0%90%D0%BB%D0%B5%D0%BA%D1%81%D0%B0%D0%BD%D0%B4%D1%80%D0%BE%D0%B2%D0%B8%D1%87%D0%96%D0%B0%D0%B2%D0%BE%D1%80%D0%BE%D0%BD%D0%BA%D0%BE%D0%B2_%D0%9E%D0%BB%D0%B5%D0%BA%D1%81%D0%B0%D0%BD%D0%B4%D1%80_%D0%9E%D0%BB%D0%B5%D0%BA%D1%81%D0%B0%D0%BD%D0%B4%D1%80%D0%BE%D0%B2%D0%B8%D1%87Q16218945
about
sameAs
Methods for structuring scientific knowledge from many areas related to aging researchDeveloping criteria for evaluation of geroprotectors as a key stage toward translation to the clinicA role for G-CSF and GM-CSF in nonmyeloid cancersDeep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic DataPotential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseasesAging Chart: a community resource for rapid exploratory pathway analysis of age-related processesA review of the biomedical innovations for healthy longevity.DNA comet Giemsa staining for conventional bright-field microscopy.Deep biomarkers of human aging: Application of deep neural networks to biomarker development.Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancerLongevity expectations in the pension fund, insurance, and employee benefits industries.Exhaustive data mining comparison of the effects of low doses of ionizing radiation, formaldehyde and dioxins.Classifying aging as a disease in the context of ICD-11.Influence of non-steroidal anti-inflammatory drugs on Drosophila melanogaster longevityEditorial: Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund PerspectivesMolecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in humanLarge-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cellsBiomedical progress rates as new parameters for models of economic growth in developed countries.In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development.Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells.Pro-fibrotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma.In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia.druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico.Applications of Deep Learning in Biomedicine.Quantifying signaling pathway activation to monitor the quality of induced pluripotent stem cellsCommon pathway signature in lung and liver fibrosis.Screening and personalizing nootropic drugs and cognitive modulator regimens in silicoPathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions.Cancer megafunds with in silico and in vitro validation: accelerating cancer drug discovery via financial engineering without financial crisisSignaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugsModels of Innate Neural Attractors and Their Applications for Neural Information Processing.Towards natural mimetics of metformin and rapamycin.From personalized medicine to personalized science: uniting science and medicine for patient-driven, goal-oriented research.Fucoxanthin increases lifespan of Drosophila melanogaster and Caenorhabditis elegans.Interview with Alex Zhavoronkov, PhD.Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare.Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells.Adversarial Threshold Neural Computer for Molecular de Novo Design.3D Molecular Representations Based on the Wave Transform for Convolutional Neural Networks.Artificial Intelligence for Drug Discovery, Biomarker Development, and Generation of Novel Chemistry
P50
Q21135290-7CB3E6F3-8834-4FFE-A087-66EA384D6E1BQ26766217-103B3264-197A-4991-B831-E3A07171B2CBQ27002515-2B8E013E-471B-4123-ADC1-9600EB5299E0Q27301054-9E51701B-6805-4A65-B5B4-66D74321F78BQ28391383-9715A478-31B3-43B8-B86E-4A5C66D8EED3Q28603043-52013328-A217-4509-98AF-36DB10DB9033Q30313504-D2519EE7-9F48-469E-9BCA-CA4BB2352993Q33580597-BA299393-A4CD-41AA-AE13-600EB177A5E7Q34527074-778DA9C6-2B01-4592-B5C4-A0EF9848FE0CQ34956969-E804BD53-B8A4-48E8-AC28-240AB93986C6Q35024229-6653302A-AACD-4654-8365-BD539FE5A410Q35539065-45C73D9F-E8D5-44E3-8733-33C8C7262C64Q36245247-C01399CD-E6D5-436B-9FA7-62E23C531BE5Q36260546-9496DCCF-B2E4-4F07-A14B-7AB65E8D3787Q36582506-23084400-90E8-4F74-8A3E-9A17E8855AB5Q36729496-838E105D-B438-4FDF-A02A-8AD277232C15Q37289808-C42555E9-8D3F-4ED8-8DA4-141A18FCC54CQ37394017-49E57D18-5DB0-4079-A3A8-987E1AFFD400Q37423763-9FDCA381-1DD4-47F7-B61F-1BA83455684DQ37530943-FBC59E67-C4B4-47AB-AE3F-12A3D60EE8DDQ38446855-6434EE5D-3929-4623-96E6-F791670932C1Q38674897-51769ADB-B28C-45A2-9438-391F45733250Q38681438-F192A460-B3B5-43C8-8395-DF04026447F2Q38786217-0B1D0723-B78C-45B1-ABF6-7F910722B622Q38839000-39DEE885-9846-4D60-91D6-53826055FBE5Q38857496-E861A430-072C-408C-B741-4673DAB1D712Q41370019-8C91A39B-3CD6-461F-9F6B-93E9F386A80EQ41807717-3EB9ABE3-1409-4222-9FF3-CE3750A282A7Q41884293-BEA0020E-3FC5-426C-9F36-7FA7A24FCBF8Q41991292-A5A588C5-F4FF-4C29-B061-B45D05AB3573Q42252944-618650D8-7749-41E7-A152-ABF278C71CA6Q47140599-F8769670-4CD1-42B8-A1C2-A5616A529AEBQ47865731-09B418A4-C827-4E5F-B583-1A81A25E3DE6Q47913384-92D0EFFA-840B-451B-9CDC-C3546FD8E4C1Q47984778-5BCE1ED6-65C7-41B3-9CBB-7E6BF23E3378Q49787893-88A68A37-3473-44D4-85E5-24B61A5718E7Q50319620-8CF93EC0-98F7-4A6C-BC21-A5937FACFB1CQ52641012-B5F473B9-5C40-481C-9191-D2B191D3C505Q52688661-CEF1CA92-7D84-4D5C-97D4-314E8DF37FEEQ57059750-A839569B-FEE4-4C44-959F-1BCF6595D9A5
P50
description
ahli biologi
@id
biotechnoloog
@nl
scientist
@en
российский учёный
@ru
հետազոտող
@hy
name
Alex Zhavoronkov
@ace
Alex Zhavoronkov
@ast
Alex Zhavoronkov
@en
Alex Zhavoronkov
@es
Alex Zhavoronkov
@fr
Alex Zhavoronkov
@id
Alex Zhavoronkov
@nl
Жаворонков Олександр Олександрович
@uk
Жаворонков, Александр Александрович
@ru
type
label
Alex Zhavoronkov
@ace
Alex Zhavoronkov
@ast
Alex Zhavoronkov
@en
Alex Zhavoronkov
@es
Alex Zhavoronkov
@fr
Alex Zhavoronkov
@id
Alex Zhavoronkov
@nl
Жаворонков Олександр Олександрович
@uk
Жаворонков, Александр Александрович
@ru
altLabel
Alex Zhavoronkoff
@en
prefLabel
Alex Zhavoronkov
@ace
Alex Zhavoronkov
@ast
Alex Zhavoronkov
@en
Alex Zhavoronkov
@es
Alex Zhavoronkov
@fr
Alex Zhavoronkov
@id
Alex Zhavoronkov
@nl
Жаворонков Олександр Олександрович
@uk
Жаворонков, Александр Александрович
@ru
P69
P214
P244
P349
P19
P21
P213
0000 0003 9956 1491
P214
P244
n2012077082
P31
P349
P496
0000-0001-7067-8966
P569
1979-08-17T00:00:00Z
P735
P7859
lccn-n2012077082